Research study Program year 2020 Source: CMS Open Payments

M16-289

ClinicalTrials.gov NCT03061812

Research payments

$505,260

141 payments

Through program year 2020, $505,260 in research payments was reported against M16-289, across 141 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03061812

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$205,316	54
2019	Research	$299,945	87

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $505,260 141 payments

Who received the money Research payments · program years 2019–2020

Ohsu Hospital And Clinics Teaching hospital · OR $74,295 9 payments
Northside Hospital Organisation paid for research $54,900 15 payments
Regents Of The University Of California Organisation paid for research $46,633 11 payments
Uc Davis Medical Center Teaching hospital · CA $30,209 3 payments
Oncology Specialties, P.C. Organisation paid for research $29,820 7 payments
University Of Texas Southwestern Medical Center At Dallas Organisation paid for research $24,010 3 payments
Upmc Hillman Cancer Center Organisation paid for research $20,437 7 payments
University Of Washington Med Ctr Teaching hospital · WA $19,930 1 payment
Brigham And Womens Physicians Organization INC Organisation paid for research $18,540 4 payments
Summit Cancer Center Organisation paid for research $17,983 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.